SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

AtriCure, Inc. – ‘10-Q’ for 9/30/19 – ‘EX-10.1’

On:  Thursday, 10/31/19, at 1:52pm ET   ·   For:  9/30/19   ·   Accession #:  1323885-19-38   ·   File #:  0-51470

Previous ‘10-Q’:  ‘10-Q’ on 7/31/19 for 6/30/19   ·   Next:  ‘10-Q’ on 4/30/20 for 3/31/20   ·   Latest:  ‘10-Q’ on 5/2/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/31/19  AtriCure, Inc.                    10-Q        9/30/19   78:12M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.08M 
 2: EX-10.1     Material Contract                                   HTML     60K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     33K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     28K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     28K 
63: R1          Document and Entity Information                     HTML     77K 
39: R2          Condensed Consolidated Balance Sheets               HTML    113K 
16: R3          Condensed Consolidated Balance Sheets               HTML     36K 
                (Parenthetical)                                                  
52: R4          Condensed Consolidated Statements of Operations     HTML     87K 
                and Comprehensive Loss                                           
62: R5          Condensed Consolidated Statements of Stockholders'  HTML     75K 
                Equity                                                           
37: R6          Condensed Consolidated Statements of Cash Flows     HTML    152K 
15: R7          Description of Business and Summary of Significant  HTML    223K 
                Accounting Policies                                              
53: R8          Recent Accounting Pronouncements                    HTML     32K 
61: R9          Fair Value                                          HTML    261K 
32: R10         Business Combinations                               HTML    156K 
25: R11         Intangible Assets And Goodwill                      HTML    129K 
46: R12         Accrued Liabilities                                 HTML     69K 
74: R13         Indebtedness                                        HTML     56K 
33: R14         Leases                                              HTML    190K 
26: R15         Commitments and Contingencies                       HTML     38K 
47: R16         Revenue                                             HTML     35K 
75: R17         Income Tax Provision                                HTML     29K 
34: R18         Equity Compensation Plans                           HTML     90K 
24: R19         Segment and Geographic Information                  HTML    228K 
55: R20         Description of Business and Summary of Significant  HTML    277K 
                Accounting Policies (Policies)                                   
64: R21         Description of Business and Summary of Significant  HTML    185K 
                Accounting Policies (Tables)                                     
35: R22         Fair Value (Tables)                                 HTML    251K 
12: R23         Business Combinations (Tables)                      HTML    139K 
56: R24         Intangible Assets And Goodwill (Tables)             HTML    131K 
65: R25         Accrued Liabilities (Tables)                        HTML     68K 
36: R26         Indebtedness (Tables)                               HTML     44K 
13: R27         Leases (Tables)                                     HTML    184K 
54: R28         Equity Compensation Plans (Tables)                  HTML     78K 
67: R29         Segment and Geographic Information (Tables)         HTML    227K 
78: R30         Description of Business and Summary of Significant  HTML     49K 
                Accounting Policies (Narrative) (Details)                        
50: R31         Description of Business and Summary of Significant  HTML     35K 
                Accounting Policies (Summary Of Inventories)                     
                (Details)                                                        
23: R32         Description of Business and Summary of Significant  HTML     46K 
                Accounting Policies (Summary Of Property And                     
                Equipment) (Details)                                             
31: R33         Description of Business and Summary of Significant  HTML     42K 
                Accounting Policies (Accumulated Other                           
                Comprehensive Income (Loss)) (Details)                           
77: R34         Fair Value (Narrative) (Details)                    HTML     55K 
49: R35         Fair Value (Financial Assets and Liabilities        HTML     60K 
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
22: R36         Fair Value (Level 3 Fair Value Measurements Using   HTML     34K 
                Significant Other Unobservable Inputs for                        
                Acquisition-Related Contingent Consideration)                    
                (Details)                                                        
29: R37         Business Combinations (Narrative) (Details)         HTML     72K 
76: R38         Business Combinations (Schedule of Components of    HTML     35K 
                Aggregate Purchase Price) (Details)                              
51: R39         Business Combinations (Summary Of Estimated Fair    HTML     60K 
                Values Of Assets Acquired And Liabilities Assumed)               
                (Details)                                                        
70: R40         Business Combinations (Summary Of Valuation Of      HTML     34K 
                Intangible Assets Acquired And Related                           
                Amortization Periods) (Details)                                  
58: R41         Business Combination (Summary Of Pro Forma          HTML     31K 
                Acquisition Information) (Details)                               
19: R42         Intangible Assets And Goodwill (Narrative)          HTML     34K 
                (Details)                                                        
42: R43         Intangible Assets And Goodwill (Company's           HTML     33K 
                Intangible Assets) (Details)                                     
69: R44         Intangible Assets And Goodwill (Future              HTML     39K 
                Amortization Expense Related to Intangible Assets                
                with Definite Lives) (Details)                                   
57: R45         Intangible Assets and Goodwill (Summary Of          HTML     28K 
                Company's Goodwill) (Details)                                    
18: R46         Accrued Liabilities (Accrued Liabilities)           HTML     46K 
                (Details)                                                        
41: R47         Indebtedness (Narrative) (Details)                  HTML     71K 
68: R48         Indebtedness (Future Maturities On Debt) (Details)  HTML     41K 
59: R49         Leases (Narrative) (Details)                        HTML     62K 
44: R50         Leases (Summary Of Components Of Lease Expense)     HTML     34K 
                (Details)                                                        
71: R51         Leases (Summary Of Supplemental Cash Flow           HTML     35K 
                Information Related To Leases) (Details)                         
27: R52         Leases (Summary Of Supplemental Balance Sheet       HTML     51K 
                Information Related To Leases) (Details)                         
20: R53         Leases (Schedule Of Maturities Of Lease             HTML     62K 
                Liabilities) (Details)                                           
45: R54         Leases (Schedule Of Future Minimum Lease Payments   HTML     37K 
                Under Non-cancelable Operating Leases) (Details)                 
72: R55         Commitments and Contingencies (Narrative)           HTML     39K 
                (Details)                                                        
28: R56         Revenue (Narrative) (Details)                       HTML     26K 
21: R57         Income Tax Provision (Narrative) (Details)          HTML     30K 
43: R58         Equity Compensation Plans (Narrative) (Details)     HTML     78K 
73: R59         Equity Compensation Plans (Share-Based              HTML     35K 
                Compensation Expense Related to Employee                         
                Share-Based Compensation) (Details)                              
40: R60         Segment and Geographic Information (Narrative)      HTML     25K 
                (Details)                                                        
17: R61         Segment and Geographic Information (Revenue by      HTML     41K 
                Geographic Area) (Details)                                       
60: R62         Segment and Geographic Information (Revenue by      HTML     55K 
                Product Type) (Details)                                          
66: XML         IDEA XML File -- Filing Summary                      XML    146K 
14: XML         XBRL Instance -- atrc-20190930x10q_htm               XML   3.56M 
38: EXCEL       IDEA Workbook of Financial Reports                  XLSX     82K 
 8: EX-101.CAL  XBRL Calculations -- atrc-20190930_cal               XML    231K 
 9: EX-101.DEF  XBRL Definitions -- atrc-20190930_def                XML    490K 
10: EX-101.LAB  XBRL Labels -- atrc-20190930_lab                     XML   1.16M 
11: EX-101.PRE  XBRL Presentations -- atrc-20190930_pre              XML    944K 
 7: EX-101.SCH  XBRL Schema -- atrc-20190930                         XSD    157K 
30: JSON        XBRL Instance as JSON Data -- MetaLinks              338±   520K 
48: ZIP         XBRL Zipped Folder -- 0001323885-19-000038-xbrl      Zip    208K 


‘EX-10.1’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Exhibit 101  

Exhibit 10.1

 



JOINDER AND THIRD AMENDMENT

to Loan and security agreement



This Joinder and Third Amendment to Loan and Security Agreement (this Amendment”) is entered into this 27th day of September, 2019, among (a) SILICON VALLEY BANK, a California corporation (“SVB”), in its capacity as Administrative Agent (“Agent”), (b) SVB, and each other lender and other financial institutions party to the Loan Agreement (as defined below) from time to time (each, a “Lender” and collectively, the “Lenders”), (c) (i) ATRICURE, INC., a Delaware corporation with its chief executive office located at 7555 Innovation Way, Mason, Ohio 45040 (“AtriCure”), (ii) ATRICURE, LLC, a Delaware limited liability company (“AtriCure LLC”), (iii) ENDOSCOPIC TECHNOLOGIES, LLC, a Delaware limited liability company (“Endoscopic”), and (iv) nCONTACT SURGICAL, LLC, a Delaware limited liability company (“nContact”, and together with AtriCure, AtriCure LLC and Endoscopic, individually and collectively, jointly and severally, the “Borrower”), and (d) SentreHEART LLC, a Delaware limited liability company (“New Borrower”).

Recitals

A.    Agent, the Lenders and the Borrower have entered into that certain Loan and Security Agreement dated as of February 23, 2018, as amended by that certain First Amendment to Loan and Security Agreement dated December 28, 2018, and as further amended by that certain Consent and Second Amendment to Loan and Security Agreement dated August 12, 2019 (as the same may from time to time be further amended, modified, supplemented or restated, the “Loan Agreement”).

B.    Lenders have extended credit to Borrower for the purposes permitted in the Loan Agreement.

C.    Borrower has requested that Agent and Lenders amend the Loan Agreement to make certain revisions to the Loan Agreement as more fully set forth herein.

D.    Agent and Lenders have agreed to so amend certain provisions of the Loan Agreement, but only to the extent, in accordance with the terms, subject to the conditions and in reliance upon the representations and warranties set forth below.

Agreement

    Now, Therefore, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:

1.    Definitions.  Capitalized terms used but not defined in this Amendment shall have the meanings given to them in the Loan Agreement.

2.    Joinder and Assumption.  New Borrower is a wholly-owned Subsidiary of AtriCure.  New Borrower hereby joins the Loan Agreement and each of the other appropriate Loan Documents, and agrees to comply with and be bound by all of the terms, conditions and


 

 

covenants of the Loan Agreement and each of the other appropriate Loan Documents, as if such New Borrower were originally named a “Borrower” and/or a “Debtor” therein.  Without limiting the generality of the preceding sentence, New Borrower hereby assumes and agrees to pay and perform when due all present and future indebtedness, liabilities and obligations of Borrower under the Loan Agreement, including, without limitation, the Obligations.  From and after the date hereof, all references in the Loan Documents to “Borrower” and/or “Debtor” shall be deemed to refer to and include New Borrower.  Further, all present and future Obligations of Borrower shall be deemed to refer to all present and future Obligations of New Borrower.  New Borrower acknowledges that the Obligations are due and owing to Agent and the Lenders from Borrower including, without limitation, New Borrower, without any defense, offset or counterclaim of any kind or nature whatsoever as of the date hereof.

3.    Grant of Security Interest.  To secure the payment and performance of all of the Obligations, New Borrower hereby grants to Agent, for the ratable benefit of the Lenders, a continuing lien upon and security interest in all of New Borrower’s now existing or hereafter arising rights and interest in the Collateral, whether now owned or existing or hereafter created, acquired, or arising, and wherever located, including, without limitation, all of New Borrower’s assets listed on Exhibit A attached hereto and all of New Borrower’s books and records relating to the foregoing and any and all claims, rights and interests in any of the above and all substitutions for, additions, attachments, accessories, accessions and improvements to and replacements, products, proceeds and insurance proceeds of any or all of the foregoing.  New Borrower represents, warrants, and covenants that the security interest granted herein is and shall at all times continue to be a first priority perfected security interest in the Collateral (subject only to Permitted Liens that are permitted pursuant to the terms of the Loan Agreement to have superior priority to Agent’s Lien under the Loan Agreement).  If New Borrower shall acquire a commercial tort claim, New Borrower shall promptly notify Agent in a writing signed by New Borrower of the general details thereof and grant to Agent, for the ratable benefit of the Lenders, in such writing a security interest therein and in the proceeds thereof, all upon the terms of the Loan Agreement, with such writing to be in form and substance reasonably satisfactory to Agent.  New Borrower further covenants and agrees that by its execution hereof it shall provide all such information, complete all such forms, and take all such actions, and enter into all such agreements, in form and substance reasonably satisfactory to Agent that are reasonably deemed necessary by Agent in order to grant and continue a valid, first perfected security interest to Agent, for the ratable benefit of the Lenders, in the Collateral (subject only to Permitted Liens that are permitted pursuant to the terms of the Loan Agreement to have superior priority to Agent’s Lien under the Loan Agreement).  New Borrower hereby authorizes Agent, on behalf of the Lenders, to file financing statements, without notice to any Borrower, with all appropriate jurisdictions in order to perfect or protect Agent’s and Lenders’ interest or rights under the Loan Agreement.  Such financing statements may indicate the Collateral as “all assets of the Debtor” or words of similar effect, or as being of an equal or lesser scope, or with greater detail, all in Agent’s discretion.

4.    Subrogation and Similar Rights.  Borrower (in each case including, without limitation, New Borrower) waives any suretyship defenses available to it under the Code or any other applicable law.  Borrower (in each case, including, without limitation, New


 

 

Borrower) waives any right to require Agent and/or any Lender to: (i) proceed against any other Borrower or any other Person; (ii) proceed against or exhaust any security; or (iii) pursue any other remedy.  Agent and/or any Lender may exercise or not exercise any right or remedy it has against any Borrower or any security it holds (including the right to foreclose by judicial or non-judicial sale) without affecting any Borrower’s liability.  Notwithstanding any other provision of this Amendment, the Loan Agreement, or any other Loan Documents, Borrower irrevocably subordinates to the prior payment in full of the Obligations and the termination of each Lender’s commitment to make Credit Extensions to Borrower and agrees not to assert or enforce prior to the payment in full of the Obligations and the termination of each Lender’s commitment to make Credit Extensions to Borrower, all rights that it may have at law or in equity (including, without limitation, any law subrogating such Borrower to the rights of Agent and/or any Lender under the Loan Agreement), to seek contribution, indemnification or any other form of reimbursement from any other Borrower or any other Person now or hereafter primarily or secondarily liable for any of the Obligations, for any payment made by a Borrower with respect to the Obligations in connection with the Loan Agreement or otherwise and all rights that it might have to benefit from, or to participate in, any security for the Obligations as a result of any payment made by any Borrower with respect to the Obligations in connection with the Loan Agreement or otherwise.  Any agreement providing for indemnification, reimbursement or any other arrangement prohibited under this Section shall be null and void.  If any payment is made to any Borrower in contravention of this section, such Borrower shall hold such payment in trust for Agent and the Lenders and such payment shall be promptly delivered to Agent for application to the Obligations, whether matured or unmatured.  Any Borrower may, acting singly, request Credit Extensions under the Loan Agreement.  Each Borrower hereby appoints the other as agent for the other for all purposes under the Loan Agreement, including with respect to requesting Credit Extensions thereunder.  Each Borrower shall be jointly and severally obligated to repay all Credit Extensions made under the Loan Agreement or any other Loan Documents, regardless of which Borrower actually received said Credit Extension, as if each Borrower directly received all Credit Extensions.

5.    Exhibit B (Compliance Certificate).  The Compliance Certificate attached to the Loan Agreement as Exhibit B is amended in its entirety and replaced with the Compliance Certificate in the form of Exhibit B attached hereto.

6.    Limitation of Amendments.

6.1    The amendments set forth in Section 5, above, are effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise prejudice any right or remedy which Agent and Lenders may now have or may have in the future under or in connection with any Loan Document.

6.2    This Amendment shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the Loan Documents, except as herein amended, are hereby ratified and confirmed and shall remain in full force and effect.


 

 

7.    Representations and Warranties.  To induce Agent and each Lender to enter into this Amendment, Borrower and New Borrower hereby represent and warrant to Agent and each Lender as follows:

7.1    Immediately after giving effect to this Amendment (a) the representations and warranties contained in the Loan Documents are true, accurate and complete in all material respects as of the date hereof (except to the extent such representations and warranties relate to an earlier date, in which case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing;

7.2    Borrower and New Borrower have the power and authority to execute and deliver this Amendment and to perform their respective obligations under the Loan Agreement, as amended by this Amendment;

7.3    The organizational documents of Borrower previously delivered to Agent either (i) remain true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect; or (ii) have been amended and have been delivered to Agent in connection with this Amendment;

7.4    The execution and delivery by Borrower and New Borrower of this Amendment and the performance by Borrower and New Borrower of their respective obligations under the Loan Agreement, as amended by this Amendment, have been duly authorized;

7.5    The execution and delivery by Borrower and New Borrower of this Amendment and the performance by Borrower and New Borrower of their respective obligations under the Loan Agreement, as amended by this Amendment, do not and will not contravene (a) any law or regulation binding on or affecting Borrower or New Borrower, (b) any contractual restriction with a Person binding on Borrower or New Borrower, (c) any order, judgment or decree of any court or other governmental or public body or authority, or subdivision thereof, binding on Borrower or New Borrower, or (d) the organizational documents of Borrower or New Borrower;

7.6    The execution and delivery by Borrower and New Borrower of this Amendment and the performance by Borrower and New Borrower of their respective obligations under the Loan Agreement, as amended by this Amendment, do not require any order, consent, approval, license, authorization or validation of, or filing, recording or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower or New Borrower, except as already has been obtained or made; and

7.7    This Amendment has been duly executed and delivered by Borrower and New Borrower and is the binding obligation of Borrower and New Borrower, enforceable against Borrower and New Borrower in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other similar laws of general application and equitable principles relating to or affecting creditors’ rights.

8.    Ratification of Intellectual Property Security Agreement.  Borrower hereby ratifies, confirms and reaffirms, all and singular, the terms and conditions of a certain Intellectual Property Security Agreement dated as of February 23, 2018, between Borrower and Agent, and acknowledges, confirms and agrees that said Intellectual Property Security


 

 

Agreement (a) contains an accurate and complete listing of all Intellectual Property Collateral (as defined therein) and (b) shall remain in full force and effect.

9.    Perfection Certificate.  Borrower hereby ratifies, confirms and reaffirms, all and singular, the terms and disclosures contained in a certain Perfection Certificate dated on February 23, 2018, as amended as set forth on Schedule 2 attached that certain First Amendment to Loan and Security Agreement dated December 28, 2018 (as amended, the “Original Perfection Certificate”) and acknowledges, confirms and agrees the disclosures and information Borrower provided to Agent in the Perfection Certificate, have not changed, and remain true, complete and correct as of the date hereof.  Borrower and New Borrower hereby agree that all references to the “Perfection Certificate” in any Loan Document shall be deemed to refer collectively to the Original Perfection Certificate and the New Borrower Perfection Certificate (as defined below).

10.    Integration.  This Amendment and the Loan Documents represent the entire agreement about this subject matter and supersede prior negotiations or agreements.  All prior agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of this Amendment and the Loan Documents merge into this Amendment and the Loan Documents.

11.    Counterparts.  This Amendment may be executed in any number of counterparts and all of such counterparts taken together shall be deemed to constitute one and the same instrument.

12.    Conditions to Effectiveness.  Borrower hereby agrees that the following documents shall be delivered to the Agent prior to or concurrently with the execution of this Amendment, each in form and substance reasonably satisfactory to the Agent:

12.1    copies, certified in a certificate executed by a duly authorized officer of New Borrower, to be true and complete as of the date of such certificate, of each of (i) the governing documents of New Borrower, as in effect on the date of such certificate, (ii) the resolutions of New Borrower authorizing the execution and delivery of this Amendment, all documents executed by it in connection herewith, and New Borrower’s performance of all of the transactions contemplated hereby, and (iii) an incumbency certificate giving the name and bearing a specimen signature of each individual who shall be so authorized;

12.2    a long-form good standing certificate of New Borrower, certified by the Secretary of State of the state of formation of New Borrower, and each jurisdiction in which New Borrower is qualified to do business, dated as of a date no earlier than thirty (30) days prior to the date hereof;

12.3    certified copies, dated as of a recent date, of UCC and other lien searches of New Borrower, as Agent may request and which shall be obtained by Agent, accompanied by written evidence (including any UCC termination statements) that the Liens revealed in any such searches either (i) will be terminated prior to or in connection with this Amendment, or (ii) will constitute Permitted Liens;


 

 

12.4    Intellectual Property search results for New Borrower, which shall be obtained by Agent;

12.5    completed exhibits to that certain Intellectual Property Security Agreement dated even date herewith by and between New Borrower and Agent;

12.6    a filed copy, which shall be filed by Agent, acknowledged by the appropriate filing office, of a UCC-1 Financing Statement, naming New Borrower as “Debtor” and Agent as “Secured Party”;

12.7    a Perfection Certificate of New Borrower, together with the duly executed signature thereto (the “New Borrower Perfection Certificate”);

12.8    Evidence satisfactory to Bank that the insurance policies and endorsements required by Section 6.7 of the Loan Agreement are in full force and effect with respect to New Borrower;

12.9    a landlord’s access and waiver agreement in favor of Agent for 300 Saginaw Drive, Redwood City, California 94063 by the landlord thereof, together with the duly executed signatures thereto;

12.10    a legal opinion (authority and enforceability) of New Borrower’s counsel dated as of the date hereof together with the duly executed signature thereto;

12.11    Borrower’s payment of Agent’s legal fees and expenses incurred in connection with this Amendment;

12.12    the original membership interest certificate for all membership interest in New Borrower together with an original, undated transfer powers satisfactory to Agent for such certificate executed in blank by an Authorized Signer of AtriCure;  and

12.13    such other documents as Agent may reasonably request.

[Signature page follows.]

 


 

 

In Witness Whereof, the parties hereto have caused this Amendment to be duly executed and delivered as of the date first written above.



The undersigned hereby certifies, to the best of his or her knowledge, that the information set out in the Perfection Certificate is true, complete and correct.





 

 

BORROWER:

 

 



 

 



 

 

ATRICURE, INC.

 

ATRICURE, LLC



 

 

By:____________________________

 

By:____________________________

Name: _________________________

 

Name: _________________________

Title: __________________________

 

Title: __________________________



 

 

ENDOSCOPIC TECHNOLOGIES, LLC

 

nCONTACT SURGICAL, LLC



 

 

By: ___________________________

 

By: ___________________________

Name:  ________________________

 

Name:  ________________________

Title:__________________________

 

Title:__________________________



 

 

SentreHEART LLC

 

 



 

 

By: __________________________

 

 

Name:  _______________________

 

 

Title:  ________________________

 

 



 

 

AGENT:

 

LENDER:



 

 

SILICON VALLEY BANK

 

SILICON VALLEY BANK



 

 

By:   ________________________

 

By:   ________________________

Name:    _____________________

 

Name:    _____________________

Title:    ______________________

 

Title:    ______________________



 

 





Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/31/19
For Period end:9/30/19
8/12/198-K
12/28/188-K
2/23/18
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/24  AtriCure, Inc.                    10-K       12/31/23  102:10M
 2/22/23  AtriCure, Inc.                    10-K       12/31/22   99:19M
 2/17/22  AtriCure, Inc.                    10-K       12/31/21  101:19M
 2/26/21  AtriCure, Inc.                    10-K       12/31/20  111:23M
Top
Filing Submission 0001323885-19-000038   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 6, 10:03:18.2pm ET